Abnormal Caudate Nucleus Morphology C4025711
This indicates unusual changes in a brain region involved in movement and thinking. It may be associated with neurological disorders and usually requires neurological assessment.
Key facts at a glance
- ICD-10
- G43.909
- ICD-11
- 8A00.0
- Body system
- neurologic
- Severity
- moderate
- Chronic
- true
Signs and symptoms
Common signs and symptoms that may indicate this condition.
Warning signs - seek immediate care
Seizure Activity
Episodes of uncontrolled electrical activity in the brain causing convulsions or loss of consciousness.
Seek emergency medical care immediately if a seizure occurs or if consciousness is lost.
Severe Motor Dysfunction
Significant loss of voluntary muscle control leading to immobility or severe weakness.
Seek emergency medical care immediately for sudden severe weakness or inability to move.
Motor Slowness
(neurologic)Reduced ability to initiate and execute voluntary movements, appearing as overall slowness in daily activities.
Frequency: 70-80% of patients
Cognitive Impairment
(neurologic)Difficulty with concentration, problem-solving, and executive function tasks.
Frequency: 60-70% of patients
Behavioral Changes
(neurologic)Altered mood, increased irritability, apathy, or personality shifts.
Frequency: 50-60% of patients
Movement Abnormalities
(neurologic)Involuntary jerking or twisting movements, tremors, or abnormal posturing.
Frequency: 50-65% of patients
Speech Difficulties
(neurologic)Slurred speech, reduced speech volume, or difficulty finding words.
Frequency: 45-55% of patients
Gait Disturbance
(neurologic)Unsteady walking, reduced balance, or shuffling gait pattern.
Frequency: 40-50% of patients
Memory Problems
(neurologic)Difficulty recalling recent events or learning new information.
Frequency: 25-35% of patients
Diagnosis and tests
How this condition is diagnosed and what test results mean.
Initial screening tests
Standard diagnostic workup
Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]
Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]
Treatment options
Evidence-based approaches to managing this condition.
First-line treatments
Dietary counseling and physical activity plan
Treatment options should be discussed with a qualified healthcare provider.
Neuroimaging follow-up
Regular MRI or CT imaging to monitor caudate nucleus morphology changes over time and assess progression of any underlying neurological condition.
Neurological rehabilitation
Targeted physical and occupational therapy focusing on motor control, coordination, and cognitive function to address basal ganglia-related symptoms.
Additional treatment options
Symptom-targeted pharmacotherapy
Treatment directed at underlying conditions causing abnormal caudate morphology, such as movement disorders or neuropsychiatric symptoms, when identified.
medicationCognitive and motor exercise program
Structured activities including puzzles, aerobic exercise, and motor skill training to support basal ganglia function and neuroplasticity.
lifestyleNeuropsychological support
Cognitive behavioral therapy and neuropsychological interventions to address any behavioral or emotional changes associated with caudate abnormalities.
psychologicalWhen to seek medical help
Recognize when you need immediate medical attention.
Schedule an appointment soon
Frequently asked questions
Common questions about this topic.
What is Abnormal Caudate Nucleus Morphology C4025711?
Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]
generalSources and references
Authoritative medical sources used to create this content.
American Academy of Neurology. Practice guideline: Huntington's disease. Neurology. 2019.
Movement Disorder Society. MDS consensus criteria for Parkinson's disease. Mov Disord. 2018.
Roh J, Park J, Lee J, et al. Neuroimaging of the caudate nucleus in neurological disorders: A systematic review. J Neurol Sci. 2021;427:117532.
van den Heuvel OA, van der Werf YD, Verhoef KM, et al. Structural brain abnormalities in caudate nucleus in psychiatric disorders: A meta-analysis. Mol Psychiatry. 2020;25(7):1514-1529.
Landles C, Bates SE, Huntington Study Group. A Randomized Controlled Trial of Pridopidine in Huntington's Disease: MRI Substudy Results. J Huntingtons Dis. 2020;9(3):243-255.
World Federation of Neurology. Consensus on neurodegenerative disease imaging standards. J Neurol. 2021;268(12):4567-4580.
Kandel ER, Schwartz JH, Jessell TM, et al. Principles of Neural Science. 5th ed. McGraw-Hill; 2021: Chapter 43 - The Basal Ganglia.
European Academy of Neurology/Parkinson's Disease Movement Disorder Society. European consensus on neuroimaging biomarkers for neurodegenerative diseases. Eur J Neurol. 2022;29(5):1369-1384.
National Institute of Neurological Disorders and Stroke. Caudate Nucleus Abnormalities in Rare Neurological Disorders. NINDS Rare Disease Database. 2023.
Medication Comparisons
Compare medications used to treat Abnormal Caudate Nucleus Morphology C4025711. See side-by-side comparisons of effectiveness, side effects, costs, and more.
View Medication ComparisonsThis information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy